Peter Wersäll

Publications
CV
Public outreach and news

Articles

Article: ACTA ONCOLOGICA. 2019;58(8):1178-1186
Radiation-induced brachial plexus toxicity after SBRT of apically located lung lesions
Lindberg K; Grozman V; Lindberg S; Onjukka E; Lax I; Lewensohn R; Wersall P
Article: MEDICAL PHYSICS. 2019;46(5):2512-2521
Impact of SBRT fractionation in hypoxia dose painting - Accounting for heterogeneous and dynamic tumor oxygenation
Lindblom EK; Ureba A; Dasu A; Wersall P; Even AJG; van Elmpt W; Lambin P; Toma-Dasu I
Article: CUREUS. 2018;10(10):e3526
Low Infection Rate After Transrectal Implantation of Gold Anchor ™ Fiducial Markers in Prostate Cancer Patients After Non-broad-spectrum Antibiotic Prophylaxis
Castellanos E; Wersall P; Tilikidis A; Andersson AH
Article: RADIOTHERAPY AND ONCOLOGY. 2018;127(3):501-506
Overall survival after stereotactic radiotherapy or surgical metastasectomy in oligometastatic renal cell carcinoma patients treated at two Swedish centres 2005-2014
Stenman M; Sinclair G; Paavola P; Wersall P; Harmenberg U; Lindskog M
Article: ACTA ONCOLOGICA. 2018;57(4):485-490
Non-linear conversion of HX4 uptake for automatic segmentation of hypoxic volumes and dose prescription
Ureba A; Lindblom E; Dasu A; Uhrdin J; Even AJG; van Elmpt W; Lambin P; Wersall P; Toma-Dasu I
Article: PHYSICA MEDICA. 2018;46:45-51
Evaluation of third treatment week as temporal window for assessing responsiveness on repeated FDG-PET-CT scans in Non-Small Cell Lung Cancer patients
Lazzeroni M; Uhrdin J; Carvalho S; van Elmpt W; Lambin P; Dasu A; Wersall P; Toma-Dasu I
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2016;22(4):676-681
Long-Term Follow-Up of Allogeneic Hematopoietic Stem Cell Transplantation for Solid Cancer
Omazic B; Remberger M; Barkholt L; Soderdahl G; Potacova Z; Wersall P; Ericzon B-G; Mattsson J; Ringden O
Article: FUTURE ONCOLOGY. 2016;12(5):637-645
Consensus statement from the International Radiosurgery Oncology Consortium for Kidney for primary renal cell carcinoma
Siva S; Ellis RJ; Ponsky L; Teh BS; Mahadevan A; Muacevic A; Staehler M; Onishi H; Wersall P; Nomiya T; Lo SS
Article: ACTA ONCOLOGICA. 2015;54(8):1096-1104
Long-term results of a prospective phase II trial of medically inoperable stage I NSCLC treated with SBRT - the Nordic experience
Lindberg K; Nyman J; Kallskog VR; Hoyer M; Lund JA; Lax I; Wersall P; Karlsson K; Friesland S; Lewensohn R
Article: HEALTH PHYSICS. 2014;107(6):555-563
RADIATION-INDUCED CHANGES IN LEVELS OF SELECTED PROTEINS IN PERIPHERAL BLOOD SERUM OF BREAST CANCER PATIENTS AS A POTENTIAL TRIAGE BIODOSIMETER FOR LARGE-SCALE RADIOLOGICAL EMERGENCIES
Deperas-Kaminska M; Bajinskis A; Marczyk M; Polanska J; Wersall P; Lidbrink E; Ainsbury EA; Guipaud O; Benderitter M; Haghdoost S; Wojcik A
Article: RADIATION ONCOLOGY. 2014;9:149
Treatment fractionation for stereotactic radiotherapy of lung tumours: a modelling study of the influence of chronic and acute hypoxia on tumour control probability
Lindblom E; Antonovic L; Dasu A; Lax I; Wersaell P; Toma-Dasu I
Article: BMC CANCER. 2014;14:408
Volumetric FDG-PET predicts overall and progression- free survival after 14 days of targeted therapy in metastatic renal cell carcinoma
Farnebo J; Gryback P; Harmenberg U; Laurell A; Wersall P; Blomqvist LK; Ullen A; Sandstrom P
Article: MUTATION RESEARCH - FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS. 2013;756(1-2):152-157
Radiation-induced stress response in peripheral blood of breast cancer patients differs between patients with severe acute skin reactions and patients with no side effects to radiotherapy
Skiold S; Naslund I; Brehwens K; Andersson A; Wersall P; Lidbrink E; Harms-Ringdahl M; Wojcik A; Haghdoost S
Article: RADIOTHERAPY AND ONCOLOGY. 2011;101(2):260-266
Toxicity after reirradiation of pulmonary tumours with stereotactic body radiotherapy
Peulen H; Karlsson K; Lindberg K; Tullgren O; Baumann P; Lax I; Lewensohn R; Wersall P
Article: LAKARTIDNINGEN. 2011;108(22-23):1248-1249
[Kidney care--a web-based registry tool and decision support. Good for follow up and therapy evaluation in metastazing renal cancer].
Harmenberg U; Wersäll P; Sandström P
Article: JOURNAL OF SURGICAL ONCOLOGY. 2009;100(6):515-517
Surgical Displacement of Risk Organs to Improve Stereotactic Radiotherapy for Liver Tumors
Gunven P; Jonas E; Wersall P; Lax I
Article: ACTA ONCOLOGICA. 2008;47(8):1578-1583
Stereotactic body radiotherapy of primary and metastatic renal lesions for patients with only one functioning kidney
Svedman C; Karlsson K; Rutkowska E; Sandstroem P; Blomgren H; Lax I; Wersaell P
Article: STRAHLENTHERAPIE UND ONKOLOGIE. 2005;181(5):293-306
Dose-response relations for anal sphincter regarding fecal leakage and blood or phlegm in stools after radiotherapy for prostate cancer -: Radiobiological study of 65 consecutive patients
Mavroidis P; al-Abany M; Helgason AR; Cronqvist A; Wersäll P; Lind H; Qvanta E; Theodorou K; Kappas C; Lind BK; Steineck G; Brahme A
Article: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2005;61(4):1035-1044
Toward a definition of a threshold for harmless doses to the anal-sphincter region and the rectum
Al-Abany M; Helgason AR; Cronqvist AKA; Lind B; Mavroidis P; Wersäll P; Lind H; Qvanta E; Steineck G
Article: BRITISH JOURNAL OF CANCER. 2004;91(4):688-694
A phase I trial of DNA vaccination with a plasmid expressing prostate-specific antigen in patients with hormone-refractory prostate cancer
Pavlenko M; Roos AK; Lundqvist A; Palmborg A; Miller AM; Ozenci V; Bergman B; Egevad L; Hellström M; Kiessling R; Masucci G; Wersäll P; Nilsson S; Pisa P
Article: BONE MARROW TRANSPLANTATION. 2003;31(4):253-261
Reduced intensity conditioning regimens -: Low-intensity conditioning and hematopoietic stem cell transplantation in patients with renal and colon carcinoma
Hentschke P; Barkholt L; Uzunel M; Mattsson J; Wersäll P; Pisa P; Martola J; Albiin N; Wernerson A; Söderberg M; Remberger M; Thörne A; Ringdén O
Article: ACTA ONCOLOGICA. 2003;42(5-6):620-633
A systematic overview of radiation therapy effects in skeletal metastases
Falkmer U; Järhult J; Wersäll P; Cavallin-Ståhl E
Article: CANCER IMMUNOLOGY, IMMUNOTHERAPY. 2002;51(5):255-262
Treatment with GM-CSF and IL-2 in patients with metastatic colorectal carcinoma induced high serum levels of neopterin and sIL-2R, an indicator of immune suppression
Skog ALH; Wersäll P; Ragnhammar P; Frödin JE; Mellstedt H
Article: ANNALS OF ONCOLOGY. 2002;13(3):441-449
Outpatient treatment with subcutaneous histamine dihydrochloride in combination with interleukin-2 and interferon-α in patients with metastatic renal cell carcinoma:: results of an open single-armed multicentre phase II study
Donskov F; von der Maase H; Henriksson R; Stierner U; Wersäll P; Nellemann H; Hellstrand K; Engman K; Naredi P
Article: ACTA ONCOLOGICA. 2002;41(6):532-542
Long-term symptoms after external beam radiation therapy for prostate cancer with three or four fields
al-Albany M; Helgason AR; Cronqvist A; Svensson C; Wersäll P; Steineck G
Article: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY. 2001;35(4):288-294
Efficacy of epoetin beta on hemoglobin, quality of life, and transfusion needs in patients with anemia due to hormone-refractory prostate cancer -: A randomized study
Johansson JE; Wersäll P; Brandberg Y; Andersson SO; Nordström L
Article: JOURNAL OF CLINICAL ONCOLOGY. 2000;18(17):3068-3077
Gemcitabine and cisplatin versus methotrexate vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: Results of a large randomized, multinational, multicenter, phase III study
von der Maase H; Hansen SW; Roberts JT; Dogliotti L; Oliver T; Moore MJ; Bodrogi I; Albers P; Knuth A; Lippert CM; Kerbrat P; Rovira PS; Wersall P; Cleall SP; Roychowdhury DF; Tomlin I; Visseren-Grul CM; Conte PF
Article: CANCER IMMUNOLOGY, IMMUNOTHERAPY. 1999;48(8):463-470
Clinical effects of monoclonal antibody 17-1A combined with granulocyte/macrophage-colony-stimulating factor and interleukin-2 for treatment of patients with advanced colorectal carcinoma
Skog ALH; Ragnhammar P; Fagerberg J; Frödin JE; Goldinger M; Koldestam H; Liljefors M; Nilsson B; Shetye J; Wersäll P; Mellstedt H
Article: ANTICANCER RESEARCH. 1999;19(4C):3409-3414
Angiostatin fragments in urine from patients with malignant disease
Sten-Linder M; Linder C; Strander H; Munck-Wikland E; Wersäll P; Linder S; Wiman B
Article: BRITISH JOURNAL OF CANCER. 1998;77(8):1311-1317
Survival in renal cell carcinoma -: a randomized evaluation of tamoxifen vs interleukin 2, α-interferon (leucocyte) and tamoxifen
Henriksson R; Nilsson S; Colleen S; Wersäll P; Helsing M; Zimmerman R; Engman K
Article: INTERNATIONAL JOURNAL OF EPIDEMIOLOGY. 1998;27(1):20-26
The decline of smoking among Swedish men.
Wersäll JP; Eklund G
Article: INTERNATIONAL JOURNAL OF CANCER. 1997;73(6):790-794
Induction of a T- and B-cell response against a unique amino acid sequence of the mouse IgG(2A) hinge region in a MAb-treated patient
Wersall P; Fagerberg J; Ohlsson I; Ruden U; Boethius J; Mellstedt H
Article: CANCER IMMUNOLOGY, IMMUNOTHERAPY. 1997;44(3):157-164
Intratumoral infusion of the monoclonal antibody, mAb 425, against the epidermal-growth-factor receptor in patients with advanced malignant glioma
Wersall P; Ohlsson I; Biberfeld P; Collins VP; vonKrusenstjerna S; Larsson S; Mellstedt H; Boethius J
Article: ACTA ONCOLOGICA. 1996;35(4):395-397
A decline in the lung cancer incidence amongst men in Swedish cities
Wersall P; Barlow L; Eklund G
Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 1995;7(5):1049-1056
DIFFERENT DOSE REGIMENS OF THE MOUSE MONOCLONAL-ANTIBODY 17-1A FOR THERAPY OF PATIENTS WITH METASTATIC COLORECTAL-CARCINOMA
RAGNHAMMAR P; FRODIN JE; HJELM AL; FAGERBERG J; WERSALL P; LINDEMALM C; NILSSON B; FOX K; MAGNUSSON I; EWERTH S; THOR K; SECHER E; MELLSTEDT H
Article: MEDICAL ONCOLOGY. 1995;12(2):69-77
INCREASED LAK AND T-CELL ACTIVATION IN RESPONDING RENAL-CELL CARCINOMA PATIENTS AFTER LOW-DOSE CYCLOPHOSPHAMIDE, IL-2 AND ALPHA-IFN
WERSALL P; MELLSTEDT H
Article: CANCER IMMUNOLOGY, IMMUNOTHERAPY. 1995;40(6):367-375
GRANULOCYTE MACROPHAGE-COLONY-STIMULATING FACTOR AUGMENTS THE INDUCTION OF ANTIBODIES, ESPECIALLY ANTIIDIOTYPIC ANTIBODIES, TO THERAPEUTIC MONOCLONAL-ANTIBODIES
RAGNHAMMAR P; FAGERBERG J; FRODIN JE; WERSALL P; HANSSON LO; MELLSTEDT H
Article: CANCER BIOTHERAPY. 1995;10(1):5-12
SUBCUTANEOUS INTERLEUKIN-2 AND ALPHA-INTERFERON IN ADVANCE COLORECTAL-CARCINOMA - A PHASE-II STUDY
HJELM AL; RAGNHAMMAR P; FAGERBERG J; MAGNUSSON I; FRODIN JE; SVANSTROM R; SHETYE J; MELLSTEDT H; WERSALL JP
Show more

All other publications

Published conference paper: ACTA ONCOLOGICA. 2017;56(6):819-825
Defining the hypoxic target volume based on positron emission tomography for image guided radiotherapy - the influence of the choice of the reference region and conversion function
Lindblom E; Dasu A; Uhrdin J; Even A; van Elmpt W; Lambin P; Wersall P; Toma-Dasu I
Meeting abstract: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2015;93(3):E577-E578
A Multinational Report on Technical Factors of Stereotactic Body Radiation Therapy for Primary Renal Cell Carcinoma
Siva S; Ellis RJIII; Ponsky L; Teh BS; Mahadevan A; Muacevic A; Onishi H; Wersall P; Nomiya T; Lo SS
Meeting abstract: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2015;93(3):E208-E209
A Multinational Report on Factors of Stereotactic Body Radiation Therapy for Primary Renal Cell Carcinoma: Patient Selection and Follow-up
Lo SS; Ellis RJIII; Ponsky L; Teh BS; Mahadevan A; Muacevic A; Onishi H; Wersall P; Nomiya T; Siva S
Published conference paper: MUTATION RESEARCH - FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS. 2015;776:128-135
Unique proteomic signature for radiation sensitive patients; a comparative study between normo-sensitive and radiation sensitive breast cancer patients
Skiold S; Azimzadeh O; Merl-Pham J; Naslund I; Wersall P; Lidbrink E; Tapio S; Harms-Ringdahl M; Haghdoost S
Published conference paper: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2013;87(3):590-595
Retrospective Cohort Study of Bronchial Doses and Radiation-Induced Atelectasis After Stereotactic Body Radiation Therapy of Lung Tumors Located Close to the Bronchial Tree
Karlsson K; Nyman J; Baumann P; Wersall P; Drugge N; Gagliardi G; Johansson K-A; Persson J-O; Rutkowska E; Tullgren O; Lax I
Editorial comment: JOURNAL OF TRANSLATIONAL MEDICINE. 2012;10:104
Stereotactic Ablative Radio Therapy (SABR) followed by immunotherapy a challenge for individualized treatment of metastatic solid tumours
Masucci GV; Wersall P; Kiessling R; Lundqvist A; Lewensohn R
Letter: ACTA ONCOLOGICA. 2007;46(6):862-863
Temporary effect of arsenic trioxide treatment of refractory extragonadal germ cell cancer
Kalkner KM; Ullen A; Wersall P; Cohn-Cedermark G
Published conference paper: ACTA ONCOLOGICA. 2006;45(7):870-875
A prospective phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinoma
Svedman C; Sandstrom P; Pisa P; Blomgren H; Lax I; Kalkner K-M; Nilsson S; Wersall P
Letter: ACTA ONCOLOGICA. 2004;43(1):117-118
Dose to the anal sphincter region and risk of fecal leakage
al-Abany M; Helgason AR; Cronqvist A; Lind B; Mavroidis P; Wersäll P; Lind H; Qvanta E; Steineck G
Published conference paper: TRANSPLANTATION PROCEEDINGS. 2001;33(1-2):1862-1864
An allogeneic anti-cancer effect after hematopoietic stem cell transplantation
Barkholt L; Hentschke P; Zetterquist H; Mattsson J; Uzunel M; Wersäll P; Martola J; Albin N; Aschan J; Wijkström H; Tillegård A; Öman S; Wernerson A; Niederwieser D; Thörne A; Ringdén O
Review: BIOELECTROCHEMISTRY. 2000;51(1):1-11
Electrochemical treatment of tumours
Nilsson E; von Euler H; Berendson J; Thörne A; Wersäll P; Näslund I; Lagerstedt AS; Narfström K; Olsson JM
Letter: BRITISH JOURNAL OF CANCER. 2000;82(1):246-247
Survival in renal cell carcinoma:: a randomized evaluation of tamoxifen vs interleukin-2, α-interferon (leucocyte) and tamoxifen -: reply
Henriksson R; Wersäll P
Published conference paper: CLINICAL ORTHOPAEDICS AND RELATED RESEARCH. 1999;(358):128-139
Failures after operation for skeletal metastatic lesions of long bones
Wedin R; Bauer HCF; Wersäll P

Employments

Affiliated to Research, Department of Oncology-Pathology, Karolinska Institutet, 2023-2026

Degrees and Education

Docent, karolinska Institutet, 1999

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI